Skip to main content
Premium Trial:

Request an Annual Quote

Agilent s Bio-Analytical Group Posts 8-Percent Revenue Growth; Sees Strong Demand for Genomics, Proteomics

NEW YORK, May 16 (GenomeWeb News) - Agilent Technologies yesterday reported 8-percent quarterly revenue growth for its Bio-Analytical Measurement segment amid an overall revenue increase of 12 percent.


For the company's second fiscal quarter ended April 30, orders in the BioAnalytical segment rose 4 percent to $401 million from $385 million in the same period of 2005.


Life sciences orders were up 4 percent, "with demand from traditional pharmaceutical customers down in the US, up modestly in Europe and up double digits in Asia compared to one year ago," the company said in a statement.


Demand for proteomics and genomics products was up more than 20 percent from last year, the company said.


Revenues for the Bio-Analytical segment increased 8 percent to $372 million from $344 million in the second quarter of 2005.


Agilent's total orders increased 21 percent to $1.59 billion from $1.32 billion, while total revenues rose 12 percent to $1.43 billion from $1.28 billion in the prior-year period.


The company's total R&D spending rose 4 percent to $197 million from $189 million in the comparable period of 2005.


Agilent's net income increased 21 percent to $115 million from $95 million.


The company held $2.7 billion in cash and cash equivalents as of April 30.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.